ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that it plans to issue financial results for the first quarter on April 26, 2007 before the market opens. Management will conduct a conference call that morning at 11:00 a.m. Eastern Time to discuss these results. The number to dial into the teleconference is 1-888-603-7990 or 1-706-679-7298 for international callers. The conference ID is 5833529. Please call in approximately ten minutes before the call is scheduled to begin. The call is also being webcast by Thomson Financial and can be accessed at BioSphere Medical’s web site: www.biospheremed.com.
